0001209191-15-054837.txt : 20150618
0001209191-15-054837.hdr.sgml : 20150618
20150618200041
ACCESSION NUMBER: 0001209191-15-054837
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150617
FILED AS OF DATE: 20150618
DATE AS OF CHANGE: 20150618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: .
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-531-5965
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FECZKO JOSEPH M
CENTRAL INDEX KEY: 0001319874
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 15941198
MAIL ADDRESS:
STREET 1: PFIZER INC ATTN CORPORATE SECRETARY
STREET 2: 235 EAST 42ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-17
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001319874
FECZKO JOSEPH M
C/O KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE
NEW YORK
NY
10022
1
0
0
0
Common Stock
2015-06-17
4
A
0
10000
0.00
A
120000
D
Stock Option (right to buy)
9.95
2015-06-17
4
A
0
30000
0.00
A
2016-06-17
2025-06-17
Common Stock
30000
30000
D
The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of June 17, 2016, June 17, 2017 and June 17, 2018.
Includes 35,000 shares of restricted stock.
The 30,000 stock options vest as to one-third on each of June 17, 2016, June 17, 2017 and June 17, 2018.
/s/ James F. Oliviero, III, Attorney-in-Fact
2015-06-18